Advertisement
Organisation › Details
Helmholtz-Zentrum München, Stem Cell Center
Start | 2017-12-14 established | |
Group | Helmholtz-Gemeinschaft (HGF) (Group) | |
Industry | stem cell research | |
Region | Neuherberg | |
Country | Germany | |
City | n. a. Neuherberg | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
Record changed: 2023-12-30 |
Advertisement
More documents for Helmholtz-Gemeinschaft (HGF) (Group)
- [1] Max-Delbrück-Centrum für Molekulare Medizin (MDC). (12/27/23). "Press Release: New Agent Regulates Serotonin Production". Berlin....
- [2] DESY. (12/14/23). "Press Release: DESY and CrystalsFirst Team Up to Speed Up the Pre-clinical Drug Discovery Process"....
- [3] Max-Delbrück-Centrum für Molekulare Medizin (MDC). (9/21/23). "Press Release: Starting Up with Highly Promising Immunotherapies"....
- [4] Helmholtz Zentrum München (Helmholtz Munich). (8/7/23). "Press Release: Life Science Factory to Open a New Location at Helmholtz Munich in 2024". Göttingen & Munich....
- [5] Helmholtz-Zentrum für Infektionsforschung (HZI. (6/27/23). "Press Release: Geneticist Josef Penninger Becomes New Scientific Director of the Helmholtz Centre for Infection Research"....
- [6] Helmholtz Institute Würzburg (HIRI). (6/20/23). "Press Release: HIRI Team Receives Funding from the Helmholtz Association Toward Spinning off Leopard Biosciences"....
- [7] Max-Delbrück-Centrum für Molekulare Medizin (MDC). (5/26/23). "Press Release: €4.6 Million for a Novel CAR T-cell Therapy". Berlin....
- [8] Helmholtz Zentrum München. (5/15/23). "Press Release: Responsible Use of Artificial Intelligence in Medicine. New Ad Hoc Working Group of BAdW in Cooperation With Helmholtz Munich Launched"....
- [9] Bicycle Therapeutics plc. (5/4/23). "Press Release: Bicycle Therapeutics Announces Collaboration With the German Cancer Research Center, to Discover and Develop Wholly Owned Bicycle® Radio Conjugates for a Range of Oncology Targets". Cambridge & Boston,...
- [10] Medigene AG. (5/2/23). "Press Release: Medigene Acquires Worldwide, Exclusive License of CD40L-CD28 Costimulatory Switch Receptor". Planegg....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top